News related to
partners establish

Smart Mobility International , a UAE-based distributor of New Energy Vehicles , has entered into a strategic partnership with IM Motors, a Chinese electric vehicle manufacturer co-founded by SAIC Motor, Alibaba Group, and Shanghai Zhangjiang Hi-Tech Park Development. This collaboration aims to introduce IM Motors’ premium electric vehicles to the United Arab Emirates , marking the brand’s inaugural entry into the Gulf Cooperation Council region.

IM Motors, established in 2020, has rapidly gained recognition for its innovative approach to electric mobility. The company’s vehicle lineup includes models such as the IM L7 sedan and the IM LS7 SUV, both of which have garnered attention for their advanced technology and design. In March 2024, IM Motors secured over 8 billion yuan in a Series B equity financing round. This funding, one of the largest investments in Chinese EV brands in recent years, was led by prominent state-backed investors, including Bank of China’s asset management unit, an investment arm of Agricultural Bank of China, and Shanghai government-backed Lingang Group. The capital infusion is earmarked for the development of new smart car models, technological advancements, and overseas expansion plans.

SMI has been proactive in aligning with the UAE’s vision for sustainable transportation. In January 2025, the company announced the opening of a specialized NEV service center in Dubai’s Al Quoz automotive district. This facility is designed to offer comprehensive maintenance services tailored to electric vehicles, including quick service areas, specialized battery care sections, and advanced diagnostic tools. The initiative reflects SMI’s commitment to supporting the UAE’s goal of increasing NEVs to 50% of the total vehicles on the nation’s roads by 2050.

The partnership between SMI and IM Motors is poised to introduce a range of premium electric vehicles to the UAE market. While specific models and timelines have yet to be announced, industry observers anticipate that IM Motors’ flagship vehicles, such as the IM L7 and IM LS7, will be among the first offerings. These models are known for their cutting-edge features, including autonomous driving capabilities, advanced infotainment systems, and impressive driving ranges.

The UAE’s automotive market has witnessed a surge in interest towards electric vehicles, driven by government initiatives promoting sustainable energy and reducing carbon emissions. The introduction of IM Motors’ vehicles is expected to cater to the growing demand for high-performance, environmentally friendly transportation options.

Singapore’s Prime Minister, Lawrence Wong, announced the formation of a dedicated task force to address the nation’s economic vulnerabilities in light of escalating global trade tensions. This initiative aims to safeguard Singapore’s economic interests and mitigate potential adverse effects on its growth trajectory.

The catalyst for this strategic move is the United States’ recent imposition of a universal 10% tariff on imports, a policy that appears non-negotiable regardless of existing trade balances or agreements. Prime Minister Wong expressed deep concern over this development, highlighting that Singapore, with its heavy reliance on global trade, could face significant economic disruptions. He indicated that the nation’s GDP growth projections for 2025, currently set between 1% and 3%, may require downward revision.

Despite the existing free trade agreement and close bilateral ties between Singapore and the U.S., the city-state has not been exempted from these tariffs. Trade Minister Gan Kim Yong voiced disappointment over the U.S. decision, noting that while the agreement permits countermeasures, Singapore has chosen not to retaliate with counter-tariffs to avoid escalating tensions and increasing import costs. Instead, the focus will be on diplomatic engagement to address specific concerns raised by the U.S. administration.

The newly established task force will comprise key government officials, industry leaders, and economic experts. Its mandate includes analyzing the potential impact of global trade policies on Singapore’s economy, formulating strategic responses, and recommending measures to bolster economic resilience. Particular attention will be given to supporting sectors most vulnerable to trade disruptions and exploring opportunities to diversify trade partnerships.

Economists anticipate that the Monetary Authority of Singapore may adjust its monetary policy in response to these challenges. The MAS, which manages policy through the Singapore dollar nominal effective exchange rate , is expected to reduce the slope of the S$NEER band. This adjustment aims to enhance export competitiveness and cushion the economy against external shocks. Analysts, including those from Fitch Solutions and Maybank, have highlighted the potential for U.S. tariffs to significantly impact Singapore’s GDP, underscoring the need for proactive policy measures.

The global economic landscape is further complicated by rising protectionism and geopolitical tensions, particularly between major economies such as the U.S. and China. These dynamics have prompted countries to adopt more assertive trade policies, leading to a fragmented global economy. Prime Minister Wong has previously cautioned that such fragmentation could result in less trade, reduced investments, and hindered economic advancement, emphasizing the importance of maintaining open economic cooperation.

Beacon Red, a subsidiary of the EDGE Group specializing in national security solutions, has entered into a strategic Memorandum of Understanding with Presight AI, a leading provider of big data analytics powered by artificial intelligence. The agreement aims to explore synergies between Presight’s advanced AI and omni-analytics capabilities and Beacon Red’s mission-focused security solutions. The partnership was formalized during the LAAD Defence & Security 2025 exhibition at the Riocentro Exhibition and Convention Center in Rio de Janeiro, Brazil.

The collaboration between Beacon Red and Presight AI is set to leverage the strengths of both entities to develop innovative security solutions. Beacon Red has a track record of tackling complex national security challenges, offering advanced solutions in areas such as cyber defense and secure communications. Presight AI, on the other hand, has established itself as a key player in the AI and big data analytics sector, with partnerships aimed at revolutionizing crisis and disaster management through the integration of advanced data analytics and AI into emergency response systems.

This alliance is expected to focus on integrating Presight’s AI-driven analytics with Beacon Red’s security platforms to enhance situational awareness and decision-making processes in security operations. By combining Presight’s capabilities in processing and analyzing vast amounts of data with Beacon Red’s expertise in security solutions, the partnership aims to deliver comprehensive tools for threat detection and response.

The MoU signifies a commitment to joint research and development efforts, with the goal of creating solutions that address emerging security challenges. Both companies have previously demonstrated a commitment to innovation and collaboration in their respective fields. Presight AI has engaged in partnerships to enhance video analytics capabilities for smart city initiatives, while Beacon Red has been recognized for fostering a high-performance culture and developing cutting-edge security solutions.

The formalization of this partnership at LAAD Defence & Security 2025 underscores the importance of international collaboration in advancing security technologies. The exhibition serves as a platform for defense and security companies to showcase innovations and forge strategic alliances. The Beacon Red and Presight AI partnership exemplifies the trend of cross-sector collaborations aimed at leveraging technological advancements to address complex security issues globally.

As the security landscape continues to evolve with the advent of new technologies and emerging threats, collaborations such as this are poised to play a crucial role in developing solutions that are both effective and adaptable. The integration of AI and big data analytics into security operations offers the potential for more proactive and informed decision-making, ultimately contributing to enhanced security outcomes.

The partnership between Beacon Red and Presight AI reflects a strategic move to harness the power of artificial intelligence in the realm of national security. By combining their respective expertise, the two companies aim to develop solutions that not only address current security challenges but also anticipate and adapt to future threats. This collaboration is indicative of a broader industry trend where technology and security firms are joining forces to create integrated solutions that leverage the latest advancements in AI and data analytics.

While specific details of the joint initiatives have not been disclosed, the partnership is expected to focus on areas where AI can significantly enhance security operations, such as predictive analytics, real-time threat detection, and automated response mechanisms. By integrating AI into security platforms, the collaboration aims to provide security professionals with tools that offer deeper insights and more efficient processes, ultimately leading to more effective security measures.

The collaboration also aligns with broader efforts within the EDGE Group to expand its capabilities in electronic warfare and cyber technologies. The group’s focus on integrating advanced technologies into its portfolio reflects a commitment to staying at the forefront of the defense and security industry. By partnering with technology firms like Presight AI, EDGE entities such as Beacon Red are positioned to offer more sophisticated and comprehensive solutions to their clients.

In the context of global security, partnerships that bridge the gap between technology and defense are becoming increasingly important. The integration of AI into security operations offers the potential to transform how threats are detected and managed, enabling more proactive and adaptive responses. As such, collaborations like the one between Beacon Red and Presight AI are not only beneficial for the companies involved but also for the broader security landscape.

The formalization of this partnership at an international event like LAAD Defence & Security 2025 highlights the global nature of security challenges and the need for cross-border collaborations to address them effectively. By coming together, companies from different regions and sectors can combine their strengths to develop solutions that are more robust and versatile.

Tether, the issuer of the world’s largest stablecoin, is evaluating the creation of a new digital currency designed to comply with forthcoming U.S. regulations. CEO Paolo Ardoino indicated that while USDT will maintain its focus on emerging markets, the proposed stablecoin would cater specifically to the U.S. market.

Ardoino emphasized Tether’s commitment to regulatory compliance, stating that the company is actively engaging with U.S. lawmakers to help shape stablecoin legislation. He noted Tether’s willingness to adapt its operations to align with legal frameworks, ensuring the company’s continued operation within the law.

The U.S. Congress is currently deliberating several bills aimed at regulating stablecoins. Notably, the STABLE Act, co-introduced by Representative Bryan Steil, proposes that stablecoin issuers maintain reserves consisting solely of high-quality liquid assets, such as U.S. Treasury bills and insured deposits. Ardoino confirmed Tether’s involvement in discussions regarding this legislation, highlighting the company’s proactive approach to compliance.

In addition to legislative engagement, Tether is expanding its global footprint. The company is finalizing the relocation of its headquarters to El Salvador after obtaining a digital asset service provider license there. This move aligns with El Salvador’s ambitions to become a digital currency trading hub, following its establishment of Bitcoin as legal tender.

Tether is also exploring opportunities beyond its traditional offerings. The company recently announced a partnership with Phoenix Group PLC to launch a Dirham -pegged stablecoin in the United Arab Emirates. This initiative aims to provide financial stability to individuals in high-inflation countries and enhance remittance services.

Tether is considering deeper involvement in the sports industry. The company holds a 5% stake in Italian Serie A soccer club Juventus and is open to increasing its investment if the current owners decide to sell more shares. This potential investment reflects Tether’s strategy to leverage its platform and user base to support global brands, particularly in emerging markets.

Eric Trump has announced a significant move into the cryptocurrency sector by partnering with Hut 8 Mining to establish American Bitcoin, a company aiming to become a leading force in Bitcoin mining. This decision follows the closure of multiple family bank accounts by major U.S. financial institutions.

In a recent interview, Eric Trump revealed that several prominent banks, including JPMorgan Chase, Bank of America, Capital One, TD Bank, and First Republic, terminated accounts associated with the Trump family. He described these actions as politically motivated and an attack on the family’s financial stability. Capital One has publicly denied these allegations, asserting that account closures are not influenced by political considerations.

The abrupt termination of these accounts prompted Eric Trump to explore decentralized financial systems, leading to his involvement in the cryptocurrency industry. He expressed that the experience underscored the vulnerabilities inherent in traditional banking and highlighted the potential of digital currencies to offer financial autonomy.

American Bitcoin emerges from a strategic partnership between the Trump-affiliated American Data Centers and Hut 8 Mining, a well-established player in the crypto-mining infrastructure sector. Under the terms of the agreement, Hut 8 holds an 80% stake in the new venture, while American Data Centers retains the remaining 20%. Eric Trump assumes the role of Chief Strategy Officer, with Matt Prusak appointed as Chief Executive Officer.

The company’s mission is to position itself as the world’s most efficient Bitcoin miner and to build a substantial strategic Bitcoin reserve. This initiative aligns with the broader objective of establishing the United States as a central hub for cryptocurrency innovation and operations. Donald Trump Jr. emphasized the family’s commitment to the value of Bitcoin, noting that mining offers opportunities beyond mere ownership of the digital asset.

The announcement of American Bitcoin has elicited varied reactions. Supporters view it as a forward-thinking move that leverages emerging technologies to circumvent traditional financial barriers. Critics, however, raise concerns about potential conflicts of interest, given the family’s political prominence, and the environmental implications associated with large-scale Bitcoin mining operations.

Pfizer has unveiled its new research and development centre in Beijing, marking a significant step in the company’s strategic expansion in China. The facility, located within the BioPark in the Beijing Economic-Technological Development Area , represents the pharmaceutical giant’s ongoing commitment to increasing its presence in the Chinese market. This development comes at a time when global healthcare companies are intensifying their focus on innovation in key Asian markets.

The opening of the R&D centre is expected to bolster Pfizer’s research capabilities, particularly in the development of cutting-edge treatments in areas such as oncology, vaccines, and rare diseases. The new centre will serve as a hub for collaborative efforts between Pfizer and local Chinese researchers, healthcare providers, and academic institutions. This collaboration is viewed as a strategic move to accelerate the discovery and delivery of new therapies tailored to both global and regional healthcare needs.

Pfizer’s decision to open a new R&D centre in Beijing underscores the company’s long-term investment in China’s growing pharmaceutical industry. It is also a response to the Chinese government’s push to modernise its healthcare infrastructure and increase the availability of advanced medical treatments to its population. China’s robust investment in healthcare innovation and its vast population present a significant opportunity for Pfizer to lead in areas of unmet medical need.

The Beijing facility will focus on the integration of new technologies, such as artificial intelligence and data analytics, into drug discovery and clinical development processes. These technologies are expected to streamline Pfizer’s ability to identify promising drug candidates more efficiently, reducing development timelines and improving outcomes for patients worldwide. The centre will also support the company’s efforts to create vaccines and treatments specifically designed for the Chinese market.

Local Chinese health experts have welcomed the initiative, highlighting the positive impact it is likely to have on the region’s pharmaceutical ecosystem. Collaborations between international pharmaceutical companies like Pfizer and domestic research institutions are seen as vital to addressing health challenges in China, including the increasing prevalence of chronic diseases and an ageing population. The government’s support of such ventures is also expected to foster a more innovative and competitive environment in the Chinese pharmaceutical sector.

Pfizer’s expansion into Beijing is not the company’s first move in the region. Over the past decade, the pharmaceutical leader has steadily increased its investments in China, with a particular focus on expanding its clinical trials and vaccine development operations. This new R&D centre further cements the company’s position as a key player in the Chinese healthcare landscape.

One of the critical drivers behind Pfizer’s decision to build the facility in Beijing is the strategic importance of the region’s role in global drug development. The Chinese market, one of the largest in the world, has seen rapid growth in demand for healthcare products, particularly in biotechnology, oncology treatments, and vaccines. With an increasingly affluent population, China’s demand for high-quality medical products has surged, presenting a strong business case for Pfizer to deepen its engagement with the market.

The opening of this facility aligns with Pfizer’s broader global strategy to strengthen its innovation pipeline and maintain its competitive edge in the pharmaceutical industry. The company has consistently emphasised the importance of R&D as a cornerstone of its business model, and this move further emphasises its commitment to discovering new therapies for complex diseases. The Beijing centre is expected to collaborate with Pfizer’s other global R&D hubs, contributing to a more interconnected and agile research network.

Pfizer’s global operations have also faced some challenges in recent years, particularly with the economic uncertainties brought on by the pandemic. However, the company’s strategy of investing in emerging markets like China reflects its resilience and focus on future growth. By establishing a physical presence in one of the world’s most dynamic pharmaceutical markets, Pfizer is positioning itself to tap into both immediate and long-term opportunities in China and beyond.

The Chinese government has been supportive of multinational companies that invest in high-tech industries such as pharmaceuticals and biotechnology. This policy environment has made it increasingly attractive for foreign companies to set up R&D centres and collaborate with Chinese firms. In return, China benefits from the influx of advanced medical technologies and expertise, further propelling its ambitions to become a leader in global healthcare innovation.

Pfizer’s Beijing R&D centre is part of a broader trend of Western pharmaceutical companies making significant investments in China. These companies are increasingly collaborating with local research institutions to foster innovation, improve patient care, and support the country’s healthcare development goals. Such investments are also aligned with China’s ongoing reforms aimed at modernising its healthcare system, ensuring broader access to innovative treatments, and addressing the nation’s rising health challenges.

The opening of the R&D centre also highlights Pfizer’s commitment to ensuring that new therapies developed in Beijing will be available not only to the Chinese market but also to the global community. With the centre poised to focus on therapies for diseases with high unmet needs, including cancer and infectious diseases, the potential for cross-border medical collaboration is immense. Pfizer’s ability to leverage the centre’s local expertise and technological advancements will play a crucial role in meeting both Chinese and global healthcare demands.

Foxconn, Apple’s primary manufacturing partner, plans to produce 25 to 30 million iPhones in India this year, more than doubling its output from the previous year. This move underscores Apple’s strategy to strengthen its manufacturing footprint in India and diversify its supply chain amid global uncertainties.

The Taiwanese contract manufacturer has been conducting trial runs at its facility in Bengaluru, Karnataka, aiming to meet Apple’s stringent quality standards and production targets. This initiative aligns with Apple’s broader objective to reduce reliance on Chinese manufacturing and mitigate risks associated with geopolitical tensions and supply chain disruptions.

Foxconn’s expansion in India is part of a larger trend of global tech companies seeking alternative manufacturing hubs. India’s Production-Linked Incentive scheme has been instrumental in attracting such investments by offering financial incentives to boost domestic manufacturing. In the fiscal year ending March 2023, Foxconn produced approximately ₹300 billion worth of iPhones, surpassing the PLI scheme’s cap of ₹200 billion, indicating the program’s success in scaling up production.

In addition to iPhone assembly, Apple is broadening its product manufacturing in India. A unit of Foxconn is set to commence the assembly of AirPods at a new factory near Hyderabad, Telangana, by early 2025, following successful trial productions. This diversification reflects Apple’s commitment to expanding its product assembly capabilities within the country.

However, the expansion has encountered challenges. Reports suggest that China is imposing restrictions on the movement of employees and specialized equipment essential for high-tech manufacturing to India and Southeast Asia. These measures appear aimed at limiting technology transfers and mitigating potential job losses, posing obstacles to Apple’s efforts to diversify its production bases.

Despite these hurdles, Apple’s manufacturing partners in India are making significant strides. Tata Electronics has acquired a 60% stake in Pegatron Technology India, which manages an iPhone plant near Chennai. This acquisition positions Tata as a formidable competitor to established players like Foxconn in the Indian iPhone manufacturing landscape.

The Indian government’s support has been pivotal in this expansion. Foxconn is establishing a mobile phone manufacturing plant in the Devanahalli Industrial Area, Bengaluru, with an investment of ₹21,911 crore. The company will receive incentives amounting to ₹6,970 crore under the Electronics System Design and Manufacturing policy, as announced by Karnataka’s Chief Minister.